Telesis Bio

Telesis Bio company information, Employees & Contact Information

Explore related pages

Related company profiles:

Telesis Bio is empowering researchers to accelerate the creation of novel synthetic biology solutions to address some of humanity’s greatest challenges. With our breakthrough automation solutions for biological synthesis and expertise in DNA biology, we enable rapid, accurate, and reproducible writing of DNA and mRNA for wide-ranging biological applications. Around the world, innovators are leveraging Telesis Bio's technology to overcome current bottlenecks in synthetic biology workflows and advance the discovery of cutting-edge solutions for health and technology. We are proud of our growing collaborations with partners that include premier academic research institutions, emerging start-ups to nearly all of the Top 25 Biopharma companies. Telesis Bio is honored to play a part in several pioneering advances of our customers and collaborators ranging from novel infectious disease vaccines, precision immunotherapy for cancer and antibody therapeutics to creation of engineered meat substitutes and sustainable cellular agricultural products.
Looking for a particular Telesis Bio employee's phone or email?

Telesis Bio Questions

News

Telesis Bio Announces Licensing Agreement with Regeneron to Adopt Gibson SOLA™ Platform for Rapid On-Site DNA and Gene Synthesis - Yahoo Finance

Telesis Bio Announces Licensing Agreement with Regeneron to Adopt Gibson SOLA™ Platform for Rapid On-Site DNA and Gene Synthesis Yahoo Finance

Telesis Bio Inks Regeneron Deal - San Diego Business Journal

Telesis Bio Inks Regeneron Deal San Diego Business Journal

Telesis Bio Secures up to $21 Million to Accelerate Adoption of Groundbreaking Gibson SOLA Technology for Rapid DNA and mRNA Synthesis - Yahoo Finance

Telesis Bio Secures up to $21 Million to Accelerate Adoption of Groundbreaking Gibson SOLA Technology for Rapid DNA and mRNA Synthesis Yahoo Finance

Telesis Bio Bullish on Future After Whirlwind Year - San Diego Business Journal

Telesis Bio Bullish on Future After Whirlwind Year San Diego Business Journal

Regeneron to deploy Telesis Bio’s platform at R&D facilities - Pharmaceutical Technology

Regeneron to deploy Telesis Bio’s platform at R&D facilities Pharmaceutical Technology

Telesis Bio Plans to Delist its Securities from The Nasdaq Stock Market - Stock Titan

Telesis Bio Plans to Delist its Securities from The Nasdaq Stock Market Stock Titan

Moving Beyond Automating Synthetic Biology to Enable Multiomic Workflows - Genetic Engineering and Biotechnology News

Moving Beyond Automating Synthetic Biology to Enable Multiomic Workflows Genetic Engineering and Biotechnology News

Telesis Bio completes sale of subsidiary EtonBio - Investing.com

Telesis Bio completes sale of subsidiary EtonBio Investing.com

Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results - Stock Titan

Telesis Bio Announces Select Preliminary Fourth Quarter 2023 Financial Results Stock Titan

Telesis Bio appoints new CEO as founder steps down - Investing.com

Telesis Bio appoints new CEO as founder steps down Investing.com

Top Telesis Bio Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant